The CDTI Innovation spent 18 million euros for the development of a linear accelerator Hadronterapia compact to fight cancer

Comienza la Fase 1 de la Compra Pública Precomercial de servicios I+D de la iniciativa Hadronterapia

Hadronterapia FASE 1
In 2018 was integrated Public Purchase of innovation in the activity of the CDTI

Cancer is one of the greatest challenges facing society today. The use of irradiation techniques of tumours is one of the essential pillars of the multidisciplinary treatment of cancer. The use of charged particles as heavy ion/proton lets take a qualitative leap in the treatment of tumors, providing a better distribution of the dose provided, reducing the collateral damage associated with the irradiation of healthy tissue, improving quality of life for patients and reducing the economic impact on the health system.

In the case of heavy ion sources, such as well as the physical properties, which provided a good line, there is a substantial advantage associated with greater efficiency regarding biological (RBE) doing highly effective radiation. However, the high costs and greater technological complexity associated with the facilities of ions radiotherapy have limited their expansion.

The current facilities of therapy with heavy ion ions, especially with emissions, are based on type sincrotrón accelerators, characterised by great size and relative complexity, with a consequent negative impact on the cost associated with the acquisition of the machine and to the facilities required.

There are currently studies designed to provide technological proposals capable of solving these problems, such as the use of new linear accelerator.

Development of a linear accelerator


In this regard,CDTI Innovationpromotes the development of a linear accelerator compact that constitutes the main instrument of an installation that will contribute to development clínico-biomédico and technological advice of the tumour therapy with ions. The prototype developed over the contract will be displayed at the facilities of theIN 2004for validation.

Data

  • Public Administration User: Consejo Superior de Investigaciones científicas (CSIC)
  • Technological challenge of the Pre-Commercial Public Purchase Hadronterapia:
  • Based on the budget bidding activities: Eur 18 million (+ vat)
  • Time frame: 55 months
  • The beginning of the implementation of phase 1: 27 december 2023
  • Adjudicatario: AVS GROUP (Added Value Industrial Engineering Solutions S.L.U)
  • Autonomous Community: Valencia


Initiative financed from funds allocated by the CDTI innovation within the framework of European Funds for Regional development (ERDF 2021-27) funded by the european Union.


Additional information on the initiativeHadronterapia.


Public purchase innovation

The Purchase of Innovation (ICC) is a tool to promote innovation from the public sector, through the acquisition of innovative solutions and solutions in the process of development.

In 2018 integrates the icc in the activity of theCDTI Innovationand in 2023 becomes entrenched in the form of Pre-Commercial Public Purchase (CPP). Under this instrument, the CDTI services Innovation acquires R & D to develop prototypes of first products or services, in the form of test series technologically innovative, and that would meet public needs. The prototype developed within the framework of these Cpc caving in to spanish Public Entity that is interested in the same and to provide the necessary environment for real validate the technology developed. The prototype will be used only as a technology demonstrator, in order to validate technology, not for commercial purposes. These initiatives are co-financed mainly from european funds.

The CDTI Innovation develops a prospective constant technology needs assessments that may have public Sector entities english to create a map of demand.


More information on thislink.

CDTIInnovation

The CDTI Innovation is the agency for financing innovation of the ministry of science, innovation and universities that promotes innovation and technological development of spanish companies, channeling requests for funding and support for r & D & I projects of spanish entities at the state and international levels. We Contribute to the improvement of the technological level of spanish companies and drive and, with an international network with coverage of 51 countries support the spanish participation in international programmes for technology cooperation and the international transfer of technology. The CDTI also supports the creation and consolidation of technology-based enterprises in Spain.

The centre for technological development and innovation, E.P.E. (CDTI) is a public entity under the ministry of Science, innovation and universities.

Further information,:

Office of the press
prensa@cdti.es
91-581.55.00

On The Internet
Website:www.cdti.es
In Linkedin:https :// www.linkedin.com/company/29815
X:https :// twitter.com/CDTI _ innovation
On Youtube:https :// www.youtube.com/user/CDTIoficial